Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes it difficult to breathe. It is caused by long-term exposure to irritants, such as cigarette smoke, dust, and fumes. COPD is a leading cause of death worldwide, and it affects millions of people.
Are you or a loved one suffering from Chronic Obstructive Pulmonary Disease (COPD)? If so, you may be interested in participating in our clinical trial. In D&H National Research Centers we are conducting research on new treatments for COPD that could potentially improve your quality of life and provide hope for a brighter future.
​
​
Our trial is designed to:
​
-
Access to innovative treatments: By participating in our clinical trial, you will have the opportunity to receive cutting-edge treatments that could potentially improve your COPD symptoms and overall quality of life.
​
-
Expert medical care: The D&H National Research Centers team of healthcare professionals and researchers will closely monitor your progress throughout the trial, ensuring that you receive the highest standard of care and support.
​
-
Contribution to medical research: By participating in our clinical trial, you will be contributing to the advancement of medical science and helping to improve the lives of future COPD patients.
​
-
Compensation: As a token of appreciation for your participation, you may be eligible for compensation for your time and travel expenses up $700.
D&H National Research Centers is currently conducting a study on Chronic obstructive pulmonary disease . As a prominent leader in clinical research in Florida, we are committed to advancing medical knowledge and patient care.
Inclusion Criteria:
If you want to participate in this study, you must meet the following criteria:
​
-
Male or female subjects aged from 40 to 65 years old (both inclusive).
-
History of chronic bronchitis symptoms (sputum and cough) and an initial diagnosis of mild to moderate COPD over the previous 12 months.
-
Subject has a smoking history of at least 10 years.
-
Subject has been smoking ≥ 10 commercially available cigarettes/day on average for at least 1 year prior to screening.
Exclusion Criteria:
You are not eligible for participation in this study if:
-
Subjects with active cancer or history of any cancer.
-
Subjects with pneumonia or other lower respiratory tract infections that have not resolved at least four weeks prior to screening.
-
Subjects with other active respiratory disorders such as, but not limited to, tuberculosis, bronchiectasis, sarcoidosis, asthma, pulmonary hypertension, interstitial lung diseases.
-
Subjects with pneumonia or other lower respiratory tract infections that have not resolved at least four weeks prior to screening.
​
D&H National Research Centers is a leading medical trial center located in Florida.
​
If you are interested in joining our COPD medical trial or have questions about the study, please don't hesitate to reach out to us. We are here to provide you with all the information and support you need, please fill the form or contact us by phone: (786) 375-6210